Dudediligence.

Bio-Rad Laboratories, Inc

BIONYSE · Laboratory Analytical Instruments
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$649.7MSep ’24$667.5MDec ’24$585.4MMar ’25$651.6MJun ’25$653.0MSep ’25$693.2MDec ’25$592.1MMar ’26$651.0MJun ’26
Net income, by quarter
$653.2MSep ’24−$715.8MDec ’24$64.0MMar ’25$317.8MJun ’25−$341.9MSep ’25$720.0MDec ’25−$527.1MMar ’26$371.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$2.92B$2.80B$2.67B$2.57B$2.58B
Gross profit$1.64B$1.57B$1.43B$1.38B$1.34B
Operating income$500.3M$482.6M$337.8M$269.0M$47.2M
Net income$4.25B−$3.63B−$637.3M−$1.84B$759.9M
Operating cash flow$669.5M$194.4M$374.9M$455.2M$532.2M
Free cash flow$535.7M$81.6M$218.2M$289.6M$374.6M
Cash$470.8M$434.2M$403.8M$488.1M$529.8M
Debt$10.5M$1.20B$1.20B$1.20B$1.20B
Shares outstanding30.2M29.8M29.2M28.2M27.3M